Physicians

Department / Division
Medicine / Medicine - Cell Therapy and Hematologica

Address
DUMC 3961
Durham, NC 27710

Appointment Telephone
919-668-1011

Office Telephone
919-668-4383

Fax Telephone
919-668-1091

Training

• MD, Indiana University School of Medicine, 1971

Residency

• Internal Medicine, University of Washington Medical Center, 1971-1973, 1975-1976
• Oncology, American Cancer Society, University of Washington School of Medicine, 1976-1978

Fellowship

• Medical Oncology, Fred Hutchinson Cancer Research Center (Washington), 1978-1979

Clinical Interests
Late effects of high-dose chemotherapy and stem-cell transplantation for hematologic malignancies, sickle cell and autoimmune disease

Research Interests

Late effects of cancer treatment and stem cell transplantation
Chronic graft-versus-host disease
Transplantation for sickle cell and autoimmune diseases
Knowledge engineering in cancer medicine

Early on, Dr. Sullivan and the team at Fred Hutchinson Cancer Research Center developed a systematic investigative approach for the diagnosis and treatment of chronic graft-versus-host disease, the major cause of late morbidity and non-relapse mortality following allogeneic stem cell transplantation (SCT). As a result of this work, it became clear that blood and marrow transplant recipients require systematic long-term follow-up to evaluate and treat late complications of high-dose chemoradiotherapy and SCT. The program grew into a large multidisciplinary team, resulting in improvement in patient outcome and quality of life. Through the late events project, he also contributed to outcomes research, computer decision support systems, and knowledge engineering for follow-up care. With quality of life as a focus, research pursued the application of SCT to diseases with high morbidity but little immediate mortality. For young patients with advanced, symptomatic sickle cell disease, myeloablative conditioning and SCT from an HLA-identical sibling has led to an 86% long-term survival free of sickle cell disease. For individuals with autoimmune diseases such as multiple sclerosis, scleroderma, systemic lupus erythematosus and juvenile rheumatoid arthritis, current therapy is often incomplete and significant morbidity from the disease or its treatment is observed. Recent preclinical and clinical data suggest that high-dose immunosupression and SCT can halt the progression and, in some settings, reverse the course of autoimmune diseases. Since his arrival at Duke University, over 30 centers nationwide are participating in Duke-led phase II and III trials to test the toxicity, efficacy, and quality of life following autologous and allogeneic stem cell transplantation for autoimmune diseases. These trials will also serve as platforms to study the immune repertoire and mechanistic pathways before and after SCT to gain greater insight into the basic mechanisms of autoimmunity. A national repository of tissue and cell specimens is also part of these NIH-supported trials to further promote scientific study from these unique patients.

Industry Relationships and Collaborations (What's this?)

This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.

• Kiadis

Representative Publications
Stevens, AM; Sullivan, KM; Nelson, JL. Polymyositis as a manifestation of chronic graft-versus-host disease. Rheumatology. 2003;42:34-39. (2003) Abstract

Goerner, M; Gooley, T; Flowers, ME; Sullivan, KM; Kiem, HP; Sanders, JE; Martin, PJ; Storb, R. Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias. Biology of Blood and Marrow Transplantation. 2002;8:47-56. (2002) Abstract

McSweeney, PA; Nash, RA; Sullivan, KM; Storek, J; Crofford, LJ; Dansey, R; Mayes, MD; McDonagh, KT; Nelson, JL; Gooley, TA; Holmberg, LA; Chen, CS; Wener, MH; Ryan, K; Sunderhaus, J; Russell, K; Rambharose, J; Storb, R; Furst, DE. High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes. Blood. 2002;100:1602-1610. (2002) Abstract

Sullivan, KM. Bone marrow transplantation for non-malignant disease. International Journal of Hematology. 2002;76 Suppl 1:169-170. (2002) Abstract

Bruno, B; Gooley, T; Sullivan, KM; Davis, C; Bensinger, WI; Storb, R; Nash, RA. Secondary failure of platelet recovery after hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation. 2001;7:154-162. (2001) Abstract

Socié, G; Clift, RA; Blaise, D; Devergie, A; Ringden, O; Martin, PJ; Remberger, M; Deeg, HJ; Ruutu, T; Michallet, M; Sullivan, KM; Chevret, S. Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies. Blood. 2001;98:3569-3574. (2001) Abstract

Stern, JM; Sullivan, KM; Ott, SM; Seidel, K; Fink, JC; Longton, G; Sherrard, DJ. Bone density loss after allogeneic hematopoietic stem cell transplantation: a prospective study. Biology of Blood and Marrow Transplantation. 2001;7:257-264. (2001) Abstract

Storek, J; Joseph, A; Espino, G; Dawson, MA; Douek, DC; Sullivan, KM; Flowers, ME; Martin, P; Mathioudakis, G; Nash, RA; Storb, R; Appelbaum, FR; Maloney, DG. Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation. Blood. 2001;98:3505-3512. (2001) Abstract

Sullivan, KM; Dykewicz, CA; Longworth, DL; Boeckh, M; Baden, LR; Rubin, RH; Sepkowitz, KA; Centers for Disease Control and Prevention, ; Infectious Diseases Society of America, ; American Society for Blood and Marrow Transplantation Practice Guidelines and beyond. Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 2001;392-421. (2001) Abstract

Walters, MC; Patience, M; Leisenring, W; Rogers, ZR; Aquino, VM; Buchanan, GR; Roberts, IA; Yeager, AM; Hsu, L; Adamkiewicz, T; Kurtzberg, J; Vichinsky, E; Storer, B; Storb, R; Sullivan, KM; Multicenter Investigation of Bone Marrow Transplantation for Sickle Cell Disease. Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biology of Blood and Marrow Transplantation. 2001;7:665-673. (2001) Abstract

Bush, NE; Donaldson, GW; Haberman, MH; Dacanay, R; Sullivan, KM. Conditional and unconditional estimation of multidimensional quality of life after hematopoietic stem cell transplantation: a longitudinal follow-up of 415 patients. Biology of Blood and Marrow Transplantation. 2000;6:576-591. (2000) Abstract

Socié, G; Curtis, RE; Deeg, HJ; Sobocinski, KA; Filipovich, AH; Travis, LB; Sullivan, KM; Rowlings, PA; Kingma, DW; Banks, PM; Travis, WD; Witherspoon, RP; Sanders, J; Jaffe, ES; Horowitz, MM. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. Journal of Clinical Oncology. 2000;18:348-357. (2000) Abstract

Stern, JM; Bruemmer, B; Moinpour, CM; Sullivan, KM; Lenssen, P; Aker, SN. Impact of a randomized, controlled trial of liberal vs conservative hospital discharge criteria on energy, protein, and fluid intake in patients who received marrow transplants. Journal of the American Dietetic Association. 2000;100:1015-1022. (2000) Abstract

Sullivan, KM; Parkman, R; Walters, MC. Bone Marrow Transplantation for Non-Malignant Disease. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 2000;319-338. (2000) Abstract

Walters, MC; Storb, R; Patience, M; Leisenring, W; Taylor, T; Sanders, JE; Buchanan, GE; Rogers, ZR; Dinndorf, P; Davies, SC; Roberts, IA; Dickerhoff, R; Yeager, AM; Hsu, L; Kurtzberg, J; Ohene-Frempong, K; Bunin, N; Bernaudin, F; Wong, WY; Scott, JP; Margolis, D; Vichinsky, E; Wall, DA; Wayne, AS; Pegelow, C; Redding-Lallinger, R; Wiley, J; Klemperer, M; Mentzer, WC; Smith, FO; Sullivan, KM. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood. 2000;95:1918-1924. (2000) Abstract

Feinstein, LC; Seidel, K; Jocum, J; Bowden, RA; Anasetti, C; Deeg, HJ; Flowers, ME; Kansu, E; Martin, PJ; Nash, RA; Storek, J; Etzioni, R; Applebaum, FR; Hansen, JA; Storb, R; Sullivan, KM. Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allografts. Biology of Blood and Marrow Transplantation. 1999;5:369-378. (1999) Abstract

Strasser, SI; Sullivan, KM; Myerson, D; Spurgeon, CL; Storer, B; Schoch, HG; Murakami, CS; McDonald, GB. Cirrhosis of the liver in long-term marrow transplant survivors. Blood. 1999;93:3259-3266. (1999) Abstract

Bichindaritz, I; Siadak, MF; Jocom, J; Moinpour, C; Kansu, E; Donaldson, G; Bush, N; Chapko, M; Bradshaw, JM; Sullivan, KM. CARE-PARTNER: a computerized knowledge-support system for stem-cell post-transplant long-term follow-up on the World-Wide-Web. Proceedings / AMIA . Annual Symposium. AMIA Symposium. 1998;386-390. (1998) Abstract

Clift, RA; Buckner, CD; Appelbaum, FR; Sullivan, KM; Storb, R; Thomas, ED. Long-term follow-Up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia. Blood. 1998;92:1455-1456. (1998) Abstract

Deeg, HJ; Leisenring, W; Storb, R; Nims, J; Flowers, ME; Witherspoon, RP; Sanders, J; Sullivan, KM. Long-term outcome after marrow transplantation for severe aplastic anemia. Blood. 1998;91:3637-3645. (1998) Abstract

Deeg, HJ; Seidel, K; Sullivan, KM. Body weight and outcome of hematopoietic stem cell transplantation. American Journal of Medicine. 1998;104:607-608. (1998) Abstract

Fink, JC; Leisenring, WM; Sullivan, KM; Sherrard, DJ; Weiss, NS. Avascular necrosis following bone marrow transplantation: a case-control study. Bone. 1998;22:67-71. (1998) Abstract

Hansen, JA; Gooley, TA; Martin, PJ; Appelbaum, F; Chauncey, TR; Clift, RA; Petersdorf, EW; Radich, J; Sanders, JE; Storb, RF; Sullivan, KM; Anasetti, C. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. New England Journal of Medicine. 1998;338:962-968. (1998) Abstract

Lopez-Cubero, SO; Sullivan, KM; McDonald, GB. Course of Crohn's disease after allogeneic marrow transplantation. Gastroenterology. 1998;114:433-440. (1998) Abstract

Morton, AJ; Gooley, T; Hansen, JA; Appelbaum, FR; Bruemmer, B; Bjerke, JW; Clift, R; Martin, PJ; Petersdorf, EW; Sanders, JE; Storb, R; Sullivan, KM; Woolfrey, A; Anasetti, C. Association between pretransplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase. Blood. 1998;92:394-401. (1998) Abstract

Storb, R; Yu, C; Deeg, HJ; Georges, G; Kiem, HP; Mcsweeney, PA; Nash, RA; Sandmaier, BM; Sullivan, KM; Wagner, JL; Walters, MC. Current and future preparative regimens for bone marrow transplantation in thalassemia. Annals of the New York Academy of Sciences. 1998;850:276-287. (1998) Abstract

Sullivan, KM; Anasetti, C; Horowitz, M; Rowlings, PA; Petersdorf, EW; Martin, PJ; Clift, RA; Walters, MC; Gooley, T; Sierra, J; Anderson, JE; Bjerke, J; Siadak, M; Flowers, ME; Nash, RA; Sanders, JE; Appelbaum, FR; Storb, R; Hansen, JA. Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia. A combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant Registry. Annals of the New York Academy of Sciences. 1998;850:312-324. (1998) Abstract

Charuhas, PM; Fosberg, KL; Bruemmer, B; Aker, SN; Leisenring, W; Seidel, K; Sullivan, KM. A double-blind randomized trial comparing outpatient parenteral nutrition with intravenous hydration: effect on resumption of oral intake after marrow transplantation. Journal of Parenteral and Enteral Nutrition. 1997;21:157-161. (1997) Abstract

Chen, CS; Seidel, K; Armitage, JO; Fay, JW; Appelbaum, FR; Horowitz, MM; Shpall, EJ; Weiden, PL; Antman, KS; Champlin, RE; Kersey, JH; Sullivan, KM. Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation. 1997;3:331-340. (1997) Abstract

Deeg, HJ; Lin, D; Leisenring, W; Boeckh, M; Anasetti, C; Appelbaum, FR; Chauncey, TR; Doney, K; Flowers, M; Martin, P; Nash, R; Schoch, G; Sullivan, KM; Witherspoon, RP; Storb, R. Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial. Blood. 1997;89:3880-3887. (1997) Abstract

McSweeney, PA; Nash, RA; Storb, R; Furst, DE; Gauthier, J; Sullivan, KM. Autologous stem cell transplantation for autoimmune diseases: issues in protocol development. The Journal of rheumatology. Supplement. 1997;48:79-84. (1997) Abstract

Nash, RA; McSweeney, PA; Storb, R; Nelson, JL; Gauthier, J; Furst, DE; Sullivan, KM. Development of a protocol for allogeneic marrow transplantation for severe systemic sclerosis: paradigm for autoimmune disease. The Journal of rheumatology. Supplement. 1997;48:72-78. (1997) Abstract

Nelson, JL; Torrez, R; Louie, FM; Choe, OS; Storb, R; Sullivan, KM. Pre-existing autoimmune disease in patients with long-term survival after allogeneic bone marrow transplantation. The Journal of rheumatology. Supplement. 1997;48:23-29. (1997) Abstract

Sierra, J; Radich, J; Hansen, JA; Martin, PJ; Petersdorf, EW; Bjerke, J; Bryant, E; Nash, RA; Sanders, JE; Storb, R; Sullivan, KM; Appelbaum, FR; Anasetti, C. Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood. 1997;90:1410-1414. (1997) Abstract

Sierra, J; Storer, B; Hansen, JA; Bjerke, JW; Martin, PJ; Petersdorf, EW; Appelbaum, FR; Bryant, E; Chauncey, TR; Sale, G; Sanders, JE; Storb, R; Sullivan, KM; Anasetti, C. Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. Blood. 1997;89:4226-4235. (1997) Abstract

Storb, R; Leisenring, W; Anasetti, C; Appelbaum, FR; Buckner, CD; Bensinger, WI; Chauncey, T; Clift, RA; Deeg, HJ; Doney, KC; Flowers, ME; Hansen, JA; Martin, PJ; Sanders, JE; Sullivan, KM; Witherspoon, RP. Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin. Blood. 1997;89:3890-3891. (1997) Abstract

Storb, R; Leisenring, W; Anasetti, C; Appelbaum, FR; Deeg, HJ; Doney, K; Martin, P; Sullivan, KM; Witherspoon, R; Pettinger, M; Bensinger, W; Buckner, CD; Clift, R; Flowers, ME; Hansen, JA; Pepe, M; Chauncey, T; Sanders, J; Thomas, ED. Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?. Biology of Blood and Marrow Transplantation. 1997;3:194-201. (1997) Abstract

Storek, J; Gooley, T; Siadak, M; Bensinger, WI; Maloney, DG; Chauncey, TR; Flowers, M; Sullivan, KM; Witherspoon, RP; Rowley, SD; Hansen, JA; Storb, R; Appelbaum, FR. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood. 1997;90:4705-4709. (1997) Abstract

Storek, J; Gooley, T; Witherspoon, RP; Sullivan, KM; Storb, R. Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts. American Journal of Hematology. 1997;54:131-138. (1997) Abstract

Sullivan, KM. Longterm followup and quality of life after hematopoietic stem cell transplantation. The Journal of rheumatology. Supplement. 1997;48:46-52. (1997) Abstract

Sullivan, KM; Furst, DE. The evolving role of blood and marrow transplantation for the treatment of autoimmune diseases. The Journal of rheumatology. Supplement. 1997;48:1-4. (1997) Abstract

Walters, MC; Patience, M; Leisenring, W; Rogers, ZR; Dinndorf, P; Davies, SC; Roberts, IA; Yeager, A; Kurtzberg, J; Bunin, N; Scott, JP; Wall, DA; Wayne, AS; Wiley, J; Darbyshire, PJ; Mentzer, WC; Smith, FO; Sullivan, KM. Collaborative multicenter investigation of marrow transplantation for sickle cell disease: current results and future directions. Biology of Blood and Marrow Transplantation. 1997;3:310-315. (1997) Abstract

Anderson, JE; Anasetti, C; Appelbaum, FR; Schoch, G; Gooley, TA; Hansen, JA; Buckner, CD; Sanders, JE; Sullivan, KM; Storb, R. Unrelated donor marrow transplantation for myelodysplasia (MDS) and MDS-related acute myeloid leukaemia. British Journal of Haematology. 1996;93:59-67. (1996) Abstract

Anderson, JE; Appelbaum, FR; Schoch, G; Gooley, T; Anasetti, C; Bensinger, WI; Bryant, E; Buckner, CD; Chauncey, TR; Clift, RA; Doney, K; Flowers, M; Hansen, JA; Martin, PJ; Matthews, DC; Sanders, JE; Shulman, H; Sullivan, KM; Witherspoon, RP; Storb, R. Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors. Blood. 1996;87:51-58. (1996) Abstract

Deeg, HJ; Socié, G; Schoch, G; Henry-Amar, M; Witherspoon, RP; Devergie, A; Sullivan, KM; Gluckman, E; Storb, R. Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood. 1996;87:386-392. (1996) Abstract

Flowers, ME; Sullivan, KM; Deeg, HJ. Graft-versus-host reactions: anti-leukemia effects of donor T cells. Transplantation Proceedings. 1996;28:1184-1185. (1996) Abstract

Kiem, HP; McDonald, GB; Myerson, D; Spurgeon, CL; Deeg, HJ; Sanders, JE; Doney, K; Appelbaum, FR; Sullivan, KM; Witherspoon, RP; Storb, R. Marrow transplantation for hepatitis-associated aplastic anemia: a follow-up of long-term survivors. Biology of Blood and Marrow Transplantation. 1996;2:93-99. (1996) Abstract

Langston, AA; Sanders, JE; Deeg, HJ; Crawford, SW; Anasetti, C; Sullivan, KM; Flowers, ME; Storb, R. Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita. British Journal of Haematology. 1996;92:758-765. (1996) Abstract

Martin, PJ; Nelson, BJ; Appelbaum, FR; Anasetti, C; Deeg, HJ; Hansen, JA; McDonald, GB; Nash, RA; Sullivan, KM; Witherspoon, RP; Scannon, PJ; Friedmann, N; Storb, R. Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation. Blood. 1996;88:824-830. (1996) Abstract

Nash, RA; Piñeiro, LA; Storb, R; Deeg, HJ; Fitzsimmons, WE; Furlong, T; Hansen, JA; Gooley, T; Maher, RM; Martin, P; McSweeney, PA; Sullivan, KM; Anasetti, C; Fay, JW. FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors. Blood. 1996;88:3634-3641. (1996) Abstract

Stern, JM; Chesnut, CH; Bruemmer, B; Sullivan, KM; Lenssen, PS; Aker, SN; Sanders, J. Bone density loss during treatment of chronic GVHD. Bone Marrow Transplantation. 1996;17:395-400. (1996) Abstract

Sullivan, KM. Immunomodulation in allogeneic marrow transplantation: use of intravenous immune globulin to suppress acute graft-versus-host disease. Clinical and Experimental Immunology. 1996;104 Suppl 1:43-48. (1996) Abstract

Sullivan, KM. Secondary immunodeficiencies and stem cell transplantation: issues of administration and safety of intravenous immunoglobulin. Clinical Therapeutics: the international peer-reviewed journal of drug therapy. 1996;18 Suppl B:126-136. (1996) Abstract

Sullivan, KM; Storek, J; Kopecky, KJ; Jocom, J; Longton, G; Flowers, M; Siadak, M; Nims, J; Witherspoon, RP; Anasetti, C; Appelbaum, FR; Bowden, RA; Buckner, CD; Crawford, SW; Deeg, HJ; Hansen, JA; McDonald, GB; Sanders, JE; Storb, R. A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery. Biology of Blood and Marrow Transplantation. 1996;2:44-53. (1996) Abstract

Wagner, JL; Deeg, HJ; Seidel, K; Anasetti, C; Doney, K; Sanders, J; Sullivan, KM; Storb, R. Bone marrow transplantation for severe aplastic anemia from genotypically HLA-nonidentical relatives. An update of the Seattle experience. Transplantation. 1996;61:54-61. (1996) Abstract

Walters, MC; Patience, M; Leisenring, W; Eckman, JR; Buchanan, GR; Rogers, ZR; Olivieri, NE; Vichinsky, E; Davies, SC; Mentzer, WC; Powars, D; Scott, JP; Bernaudin, F; Ohene-Frempong, K; Darbyshire, PJ; Wayne, A; Roberts, IA; Dinndorf, P; Brandalise, S; Sanders, JE; Matthews, DC; Appelbaum, FR; Storb, R; Sullivan, KM. Barriers to bone marrow transplantation for sickle cell anemia. Biology of Blood and Marrow Transplantation. 1996;2:100-104. (1996) Abstract

Walters, MC; Patience, M; Leisenring, W; Eckman, JR; Scott, JP; Mentzer, WC; Davies, SC; Ohene-Frempong, K; Bernaudin, F; Matthews, DC; Storb, R; Sullivan, KM. Bone marrow transplantation for sickle cell disease. New England Journal of Medicine. 1996;335:369-376. (1996) Abstract

Benyunes, MC; Sullivan, KM; Deeg, HJ; Mori, M; Meyer, W; Fisher, L; Bensinger, R; Jack, MK; Hicks, J; Witherspoon, R. Cataracts after bone marrow transplantation: long-term follow-up of adults treated with fractionated total body irradiation. International Journal of Radiation: Oncology - Biology - Physics. 1995;32:661-670. (1995) Abstract

Bush, NE; Haberman, M; Donaldson, G; Sullivan, KM. Quality of life of 125 adults surviving 6-18 years after bone marrow transplantation. Social Science and Medicine. 1995;40:479-490. (1995) Abstract

Doney, KC; Storb, R; Beach, K; Anasetti, C; Deeg, HJ; Hansen, JA; Martin, PJ; Nash, RA; Schubert, MM; Sullivan, KM. A toxicity study of trimetrexate used in combination with cyclosporine as acute graft-versus-host disease prophylaxis in HLA-mismatched, related donor bone marrow transplants. Transplantation. 1995;60:55-58. (1995) Abstract

Kalhs, P; Schwarzinger, I; Anderson, G; Mori, M; Clift, RA; Storb, R; Buckner, CD; Appelbaum, FR; Hansen, JA; Sullivan, KM. A retrospective analysis of the long-term effect of splenectomy on late infections, graft-versus-host disease, relapse, and survival after allogeneic marrow transplantation for chronic myelogenous leukemia. Blood. 1995;86:2028-2032. (1995) Abstract

Walters, MC; Sullivan, KM; Bernaudin, F; Souillet, G; Vannier, JP; Johnson, FL; Lenarsky, C; Powars, D; Bunin, N; Ohene-Frempong, K. Neurologic complications after allogeneic marrow transplantation for sickle cell anemia. Blood. 1995;85:879-884. (1995) Abstract

Deeg, HJ; Anasetti, C; Petersdorf, E; Storb, R; Doney, K; Hansen, JA; Sanders, J; Sullivan, KM; Appelbaum, FR. Cyclophosphamide plus ATG conditioning is insufficient for sustained hematopoietic reconstitution in patients with severe aplastic anemia transplanted with marrow from HLA-A, B, DRB matched unrelated donors. Blood. 1994;83:3417-3418. (1994) Abstract

Johnson, FL; Mentzer, WC; Kalinyak, KA; Sullivan, KM; Abboud, MR. Bone marrow transplantation for sickle cell disease. The United States experience. American Journal of Pediatric Hematology/Oncology. 1994;16:22-26. (1994) Abstract

Robinson, N; Sullivan, KM. Complications of allogeneic bone marrow transplantation. Current Opinion in Hematology. 1994;1:406-411. (1994) Abstract

Sanders, JE; Storb, R; Anasetti, C; Deeg, HJ; Doney, K; Sullivan, KM; Witherspoon, RP; Hansen, J. Marrow transplant experience for children with severe aplastic anemia. American Journal of Pediatric Hematology/Oncology. 1994;16:43-49. (1994) Abstract

Seidler, CW; Mills, LE; Flowers, ME; Sullivan, KM. Spontaneous factor VIII inhibitor occurring in association with chronic graft-versus-host disease. American Journal of Hematology. 1994;45:240-243. (1994) Abstract

Siadak, M; Sullivan, KM. The management of chronic graft-versus-host disease. Blood Reviews. 1994;8:154-160. (1994) Abstract

Siadak, MF; Kopecky, K; Sullivan, KM. Reduction in transplant-related complications in patients given intravenous immuno globulin after allogeneic marrow transplantation. Clinical and Experimental Immunology. 1994;97 Suppl 1:53-57. (1994) Abstract

Walters, MC; Sullivan, KM; O'Reilly, RJ; Boulad, F; Brockstein, J; Blume, K; Amylon, M; Johnson, FL; Klemperer, M; Graham-Pole, J. Bone marrow transplantation for thalassemia. The USA experience. American Journal of Pediatric Hematology/Oncology. 1994;16:11-17. (1994) Abstract

Greinix, HT; Storb, R; Sanders, JE; Deeg, HJ; Doney, KC; Sullivan, KM; Witherspoon, RP. Long-term survival and cure after marrow transplantation for congenital hypoplastic anaemia (Diamond-Blackfan syndrome). British Journal of Haematology. 1993;84:515-520. (1993) Abstract

Haberman, M; Bush, N; Young, K; Sullivan, KM. Quality of life of adult long-term survivors of bone marrow transplantation: a qualitative analysis of narrative data. Oncology Nursing Forum. 1993;20:1545-1553. (1993) Abstract

Sullivan, KM. Marrow transplantation for disorders of hematopoiesis. Leukemia. 1993;7:1098-1099. (1993) Abstract

Syrjala, KL; Chapko, MK; Vitaliano, PP; Cummings, C; Sullivan, KM. Recovery after allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning. Bone Marrow Transplantation. 1993;11:319-327. (1993) Abstract

de Oliveira, JS; Auerbach, SB; Sullivan, KM; Sale, GE. Fatal eosinophilia myalgia syndrome in a marrow transplant patient attributed to total parenteral nutrition with a solution containing tryptophan. Bone Marrow Transplantation. 1993;11:163-167. (1993) Abstract

Anasetti, C; Martin, PJ; Storb, R; Appelbaum, FR; Beatty, PG; Davis, J; Doney, K; Hill, HF; Stewart, P; Sullivan, KM. Treatment of acute graft-versus-host disease with a nonmitogenic anti-CD3 monoclonal antibody. Transplantation. 1992;54:844-851. (1992) Abstract

Clift, RA; Buckner, CD; Appelbaum, FR; Schoch, G; Petersen, FB; Bensinger, WI; Sanders, J; Sullivan, KM; Storb, R; Singer, J. Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia. Journal of Clinical Oncology. 1992;10:1723-1729. (1992) Abstract

DeGast, GC; Mickelson, EM; Beatty, PG; Amos, D; Sullivan, KM; Schoch, HG; Thomas, ED; Hansen, JA. Mixed leukocyte culture reactivity and graft-versus-host disease in HLA-identical marrow transplantation for leukemia. Bone Marrow Transplantation. 1992;9:87-90. (1992) Abstract

Deeg, HJ; Erickson, K; Storb, R; Sullivan, KM. Photoinactivation of lymphohemopoietic cells: studies in transfusion medicine and bone marrow transplantation. Blood Cells. 1992;18:151-161. (1992) Abstract

Flowers, ME; Doney, KC; Storb, R; Deeg, HJ; Sanders, JE; Sullivan, KM; Bryant, E; Witherspoon, RP; Appelbaum, FR; Buckner, CD. Marrow transplantation for Fanconi anemia with or without leukemic transformation: an update of the Seattle experience. Bone Marrow Transplantation. 1992;9:167-173. (1992) Abstract

Fried, RH; Murakami, CS; Fisher, LD; Willson, RA; Sullivan, KM; McDonald, GB. Ursodeoxycholic acid treatment of refractory chronic graft-versus-host disease of the liver. Annals of Internal Medicine. 1992;116:624-629. (1992) Abstract

Petersen, FB; Buckner, CD; Appelbaum, FR; Sanders, JE; Bensinger, WI; Storb, R; Deeg, HJ; Witherspoon, RP; Sullivan, KM; Clift, RA. Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study. Bone Marrow Transplantation. 1992;10:83-88. (1992) Abstract

Petersen, FB; Deeg, HJ; Buckner, CD; Appelbaum, FR; Storb, R; Clift, RA; Sanders, JE; Bensinger, WI; Witherspoon, RP; Sullivan, KM. Marrow transplantation following escalating doses of fractionated total body irradiation and cyclophosphamide--a phase I trial. International Journal of Radiation: Oncology - Biology - Physics. 1992;23:1027-1032. (1992) Abstract

Storb, R; Martin, P; Deeg, HJ; Sanders, JE; Pepe, M; Singer, J; Anasetti, C; Stewart, P; Appelbaum, FR; Sullivan, KM. Long-term follow-up of three controlled trials comparing cyclosporine versus methotrexate for graft-versus-host disease prevention in patients given marrow grafts for leukemia. Blood. 1992;79:3091-3092. (1992) Abstract

Sullivan, KM; Mori, M; Sanders, J; Siadak, M; Witherspoon, RP; Anasetti, C; Appelbaum, FR; Bensinger, W; Bowden, R; Buckner, CD. Late complications of allogeneic and autologous marrow transplantation. Bone Marrow Transplantation. 1992;10 Suppl 1:127-134. (1992) Abstract

Tanaka, K; Aki, T; Shulman, HM; Sullivan, KM; Tanaka, A; Nagasako, R. Two cases of transfusion-associated graft-vs-host disease after open heart surgery. Archives of Dermatology. 1992;128:1503-1506. (1992) Abstract

Witherspoon, RP; Storb, R; Pepe, M; Longton, G; Sullivan, KM. Cumulative incidence of secondary solid malignant tumors in aplastic anemia patients given marrow grafts after conditioning with chemotherapy alone. Blood. 1992;79:289-291. (1992) Abstract

Nemunaitis, J; Singer, JW; Buckner, CD; Mori, T; Laponi, J; Hill, R; Storb, R; Sullivan, KM; Hansen, JA; Appelbaum, FR. Long-term follow-up of patients who received recombinant human granulocyte-macrophage colony stimulating factor after autologous bone marrow transplantation for lymphoid malignancy. Bone Marrow Transplantation. 1991;7:49-52. (1991) Abstract

Sullivan, KM; Agura, E; Anasetti, C; Appelbaum, F; Badger, C; Bearman, S; Erickson, K; Flowers, M; Hansen, J; Loughran, T. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Seminars in Hematology. 1991;28:250-259. (1991) Abstract

Sullivan, KM; Reid, CD. Introduction to a symposium on sickle cell anemia: current results of comprehensive care and the evolving role of bone marrow transplantation. Seminars in Hematology. 1991;28:177-179. (1991) Abstract

Tanaka, K; Sullivan, KM; Shulman, HM; Sale, GE; Tanaka, A. A clinical review: cutaneous manifestations of acute and chronic graft-versus-host disease following bone marrow transplantation. Journal of Dermatology. 1991;18:11-17. (1991) Abstract

Van der Jagt, RH; Appelbaum, FR; Petersen, FB; Bigelow, CL; Fisher, LD; Schoch, GH; Buckner, CD; Sanders, JE; Storb, R; Sullivan, KM. Busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation in patients with prior chest radiotherapy. Bone Marrow Transplantation. 1991;8:211-215. (1991) Abstract

deGast, GC; Beatty, PG; Amos, D; Mickelson, EM; Sullivan, KM; Anderson, JE; Giblett, ER; Appelbaum, F; Storb, R; Deeg, HJ. Transfusions shortly before HLA-matched marrow transplantation for leukemia are associated with a decrease in chronic graft-versus-host disease. Bone Marrow Transplantation. 1991;7:293-295. (1991) Abstract

Flowers, ME; Pepe, MS; Longton, G; Doney, KC; Monroe, D; Witherspoon, RP; Sullivan, KM; Storb, R. Previous donor pregnancy as a risk factor for acute graft-versus-host disease in patients with aplastic anaemia treated by allogeneic marrow transplantation. British Journal of Haematology. 1990;74:492-496. (1990) Abstract

Higano, CS; Brixey, M; Bryant, EM; Durnam, DM; Doney, K; Sullivan, KM; Singer, JW. Durable complete remission of acute nonlymphocytic leukemia associated with discontinuation of immunosuppression following relapse after allogeneic bone marrow transplantation. A case report of a probable graft-versus-leukemia effect. Transplantation. 1990;50:175-177. (1990) Abstract

Hill, HF; Chapman, CR; Kornell, JA; Sullivan, KM; Saeger, LC; Benedetti, C. Self-administration of morphine in bone marrow transplant patients reduces drug requirement. Pain. 1990;40:121-129. (1990) Abstract

Lenssen, P; Sherry, ME; Cheney, CL; Nims, JW; Sullivan, KM; Stern, JM; Moe, G; Aker, SN. Prevalence of nutrition-related problems among long-term survivors of allogeneic marrow transplantation. Journal of the American Dietetic Association. 1990;90:835-842. (1990) Abstract

Petersen, FB; Appelbaum, FR; Hill, R; Fisher, LD; Bigelow, CL; Sanders, JE; Sullivan, KM; Bensinger, WI; Witherspoon, RP; Storb, R. Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle. Journal of Clinical Oncology. 1990;8:638-647. (1990) Abstract

Schubert, MM; Sullivan, KM. Recognition, incidence, and management of oral graft-versus-host disease. NCI Monographs. 1990;135-143. (1990) Abstract

Storb, R; Pepe, M; Anasetti, C; Appelbaum, FR; Beatty, P; Doney, K; Martin, P; Stewart, P; Sullivan, KM; Witherspoon, R. What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?. Blood. 1990;76:1037-1045. (1990) Abstract

Sullivan, KM. Chronic graft-versus-host disease. Cancer Treatment and Research. 1990;50:79-98. (1990) Abstract

Sullivan, KM; Appelbaum, FR. Comparative trials of chemotherapy and bone marrow transplantation in acute nonlymphocytic leukemia. Rinsho ketsueki/The Japanese journal of clinical hematology. 1990;31:527-533. (1990) Abstract

Sullivan, KM; Kopecky, KJ; Jocom, J; Fisher, L; Buckner, CD; Meyers, JD; Counts, GW; Bowden, RA; Peterson, FB; Witherspoon, RP. Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. New England Journal of Medicine. 1990;323:705-712. (1990) Abstract

Sullivan, KM; Meyers, J; Petersen, FB; Bowden, R; Counts, GC; Banaji, M; Schubert, M; Clark, J; Clift, RA; Appelbaum, FR. Supportive care of the marrow transplant recipient: the Seattle Experience. Haematology and blood transfusion. 1990;33:539-545. (1990) Abstract

Chapko, MK; Syrjala, KL; Schilter, L; Cummings, C; Sullivan, KM. Chemoradiotherapy toxicity during bone marrow transplantation: time course and variation in pain and nausea. Bone Marrow Transplantation. 1989;4:181-186. (1989) Abstract

Hill, HF; Chapman, CR; Jackson, TL; Sullivan, KM. Assessment and management of donor pain following marrow harvest for allogeneic bone marrow transplantation. Bone Marrow Transplantation. 1989;4:157-161. (1989) Abstract

Sullivan, KM. Congress review: progress and prospects in bone marrow transplantation. Transplantation Proceedings. 1989;21:2919-2922. (1989) Abstract

Sullivan, KM. Intravenous immune globulin prophylaxis in recipients of a marrow transplant. Journal of Allergy and Clinical Immunology. 1989;84:632-638. (1989) Abstract

Sullivan, KM; Storb, R; Buckner, CD; Fefer, A; Fisher, L; Weiden, PL; Witherspoon, RP; Appelbaum, FR; Banaji, M; Hansen, J. Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms. New England Journal of Medicine. 1989;320:828-834. (1989) Abstract

Sullivan, KM; Weiden, PL; Storb, R; Witherspoon, RP; Fefer, A; Fisher, L; Buckner, CD; Anasetti, C; Appelbaum, FR; Badger, C. Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood. 1989;73:1720-1728. (1989) Abstract

Sullivan, KM; Witherspoon, RP; Storb, R; Buckner, CD; Sanders, J; Thomas, ED. Long-term results of allogeneic bone marrow transplantation. Transplantation Proceedings. 1989;21:2926-2928. (1989) Abstract